These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 10769646

  • 1. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI.
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [Abstract] [Full Text] [Related]

  • 2. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA, Kwock R, Avramis VI.
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W.
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
    Fu CH, Martin-Aragon S, Weinberg KI, Ardi VC, Danenberg PV, Avramis VI.
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
    [Abstract] [Full Text] [Related]

  • 5. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH, Li JY, Xia XM, Zhu MQ, Geng MJ, Chen L, Zhang JQ.
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [Abstract] [Full Text] [Related]

  • 6. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
    Majlessipour F, Kwock R, Martin-Aragon S, Weinberg KI, Avramis VI.
    Anticancer Res; 2001 Dec; 21(1A):11-22. PubMed ID: 11299723
    [Abstract] [Full Text] [Related]

  • 7. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.
    Avramis VI, Nandy P, Kwock R, Solorzano MM, Mukherjee SK, Danenberg P, Cohen LJ.
    Anticancer Res; 1998 Dec; 18(4A):2327-38. PubMed ID: 9703875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B, Staren ED, Iwamura T, Appert HE, Howard JM.
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [Abstract] [Full Text] [Related]

  • 12. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
    Nandy P, Periclou AP, Avramis VI.
    Anticancer Res; 1998 Aug; 18(2A):727-37. PubMed ID: 9615712
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H, Urasaki Y, Yoshida A, Fukushima T, Ueda T.
    Cancer Res; 2001 Jan 01; 61(1):172-7. PubMed ID: 11196156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
    Guedez L, Suresh A, Tung F, Zucali J.
    Eur J Haematol; 1996 Aug 01; 57(2):149-56. PubMed ID: 8856092
    [Abstract] [Full Text] [Related]

  • 18. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
    Ohi Y, Kim R, Toge T.
    Int J Oncol; 2000 May 01; 16(5):959-69. PubMed ID: 10762632
    [Abstract] [Full Text] [Related]

  • 19. Resistance to apoptotic cell death in a drug resistant T cell leukaemia cell line.
    Geyp M, Ireland CM, Pittman SM.
    Leukemia; 1996 Mar 01; 10(3):447-55. PubMed ID: 8642860
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.